Education and Specialization
Ondokuz Mayıs University Faculty of Medicine, Professor
Ondokuz Mayıs University Faculty of Medicine, Associate Professor
Ondokuz Mayıs University Faculty of Medicine, Assistant Professor
Ankara Hospital, Infectious Diseases and Clinical Microbiology Specialist
Ankara University Faculty of Medicine, Doctor

Experience
Samsun Liv Hospital
Ondokuz Mayıs University Faculty of Medicine
Ankara Hospital

Professional Memberships
World Association of Medical Editors (WAME)
Committee of Publication Ethics (COPE)
European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
Turkish Society of Infectious Diseases and Clinical Microbiology Specialists (EKMUD)
Turkish Microbiology Society (TMC)
Viral Hepatitis Prevention Society (VHSD)
Samsun Medical Chamber
Honorary Chair of ESCMID Travel Infections Working Group
Turkey Coordinator of the International Nosocomial Infection Control Consortium (INICC)

• Annals of Clinical Microbiology and Antimicrobials Dergisi kurucusu ve baş editörü, Travel Medicine and Infectious Disease Dergisi editörüdür.
• Prof. Dr. Hakan Leblebicioğlu’nun ulusal dergilerde yayınlanmış 76 makalesi, uluslararası dergilerde basılmış 169 yayını, 12 kitap editörlüğü mevcuttur. Beş uluslararası kitapta bölüm yazarıdır. Yayınlarına Science Citation Index (SCI) kapsamındaki dergilerde 4540 atıf yapılmıştır. H indeksi 36’dir.
• İletişim ve sunum teknikleri, proje ve makale yazımı konularında eğitimler vermiş, kurslar düzenlemiştir.

Uluslararası kitaplar

• Leblebicioglu H. Crimean-Congo hemorrhagic fever. In: Hirsch MA, ed. UpToDate. Waltham, MA.: UpToDate; 2018.
• Rojek A, Carson G, Kato Y, Horby PW, Leblebicioglu H. Viral Hemorrhagic Fevers. In: Cohen J, Powderly WG, Opal SM. (eds) Infectious Diseases. 4. Ed. Elsevier. 2017:1110–1118.e2
• Leblebicioglu H. Crimean-Congo hemorrhagic fever. In: Kasper, DL., Fauci, AS., Hauser, SL., Longo, DL., Jameson, JL. Loscalzo, J. (eds) Harrison's Principles of Internal Medicine Updates. 19th Ed. Updates. New York: McGraw Hill Education. 2017.
• Pshenichnaya N., Chulanov V., Leblebicioglu H. Epidemiology of Hepatitis B. In: Ozaras R., Tahan V. (eds) Viral Hepatitis: Chronic Hepatitis B. Springer, Cham. 2018.
• Chulanov V., Pshenichnaya N., Leblebicioglu H. Genetic Diversity of the Hepatitis B Virus and Its Epidemiological Significance. In: Ozaras R., Tahan V. (eds) Viral Hepatitis: Chronic Hepatitis B. Springer, Cham. 2018.
• Ozaras, R., Leblebicioglu H. Global Epidemiology of Hepatitis C Virus Infection. In: Ozaras R., Salmon-Ceron D. (eds) Viral Hepatitis: Chronic Hepatitis C. Springer, Cham. 2019.

Uluslararası yayınlar

• Tüm yıllar için tıklayınız. http://www.scopus.com/authid/detail.uri?origin=resultslist&authorId=24073322700&zone=
• https://publons.com/researcher/2321282/hakan-leblebicioglu/
•  

Seçilmiş yayınlar 2017-2020

• Pshenichnaya NY, Leblebicioglu H, Bozkurt I, Sannikova IV, Abuova GN, Zhuravlev AS, Barut S, Shermetova MB, Fletcher TE. Crimean-Congo hemorrhagic fever in pregnancy: A systematic review and case series from Russia, Kazakhstan and Turkey. Int J Infect Dis 2017;58:58-64.
• Al-Abri SS, Abaidani IA, Fazlalipour M, Mostafavi E, Leblebicioglu H, Pshenichnaya N, Memish ZA, Hewson R, Petersen E, Mala P, Nhu Nguyen TM, Rahman Malik M, Formenty P, Jeffries R. Current status of Crimean-Congo haemorrhagic fever in the World Health Organization Eastern Mediterranean Region: issues, challenges, and future directions. Int J Infect Dis 2017;58:82-89.
• Bozkurt I, Coksevim M, Cevik BI, Gulel O, Tanyel E, Leblebicioglu H. Infective endocarditis with atypical clinical feature and relapse by Abiotrophia defectiva: Case report. J Saudi Heart Assoc 2017;29(2):136-138.
• Leblebicioglu H, Ozaras R, Sunbul M. Crimean-Congo Hemorrhagic Fever: A neglected infectious diseases with potential nosocomial infection threat. Am J Infect Control 2017;45(1):815-16.
• Fletcher TE, Gulzhan A, Ahmeti S, Al-Abri SS, Asik Z, Atilla A, Beeching NJ, Bilek H, Bozkurt I, Christova I, Duygu F, Esen S, Khanna A, Kader Ç, Mardani M, Mahmood F, Mamuchishvili N, Pshenichnaya N, Sunbul M, Yalcin TY, Leblebicioglu H. Infection prevention and control practice for Crimean-Congo hemorrhagic fever-A multi-center cross-sectional survey in Eurasia. PLoS One 2017;12(9): e0182315
• Sunbul M, Cerik H, Cerik B, Gulel O, Leblebicioglu H. A fatal case of Enterococcus durans endocarditis and literature review. American Journal of Therapeutics 2018;25:e663-5.
• Leblebicioglu H, Arends JE, Ozaras R, Corti G, Santos L, Boesecke C, Ustianowski A, Duberg AS, Ruta S, Salkic NN, Husa P, Lazarevic I, Pineda JA, Pshenichnaya NY, Tsertswadze T, Matičič M, Puca E, Abuova G, Gervain J, Bayramli R, Ahmeti S, Koulentaki M, Kilani B, Vince A, Negro F, Sunbul M, Salmon D; ESGHV (part of ESCMID). Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countries. Antiviral Res 2018;150:9-14.
• Faria LC, Terrabuio DRB, Leblebicioglu H, Huprikar S. Viral Hepatitis Recommendations for Solid-Organ Transplant Recipients and Donors. Transplantation 2018;102(2S Suppl 2):S66-S71.
• Clemente WT, Pierrotti LC, Abdala E, Morris MI, Azevedo LS, López-Vélez R, Cuenca-Estrella M, Torre-Cisneros J, Petersen E, Camargo LFA, Wright AJ, Beeching NJ, Vilela EG, Santoro-Lopes G, Len O, Stucchi RSB, Manuel O, Faria LC, Leblebicioglu H, Huprikar S, Molina I, Mourão PHO, Kotton CN, Aguado JM; working group on Endemic Disease and Travel Medicine in Solid-Organ Transplantation. Recommendations for Management of Endemic Diseases and Travel Medicine in Solid-Organ Transplant Recipients and Donors: Latin America. Transplantation 2018;102(2):193-208.
• Leblebicioglu H, Ozaras R. Hepatitis E virus infection in Turkey: a systematic review. Ann Clin Microbiol Antimicrob 2018 May 2;17(1):17.
• Fletcher TE, Leblebicioglu H, Bozkurt I, Sunbul M, Bilek H, Asik Z, Barut S, Gunes F, Gemici U, Hewson R, Wilson D, O'Shea MK, Woolley T, Faragher B, Parmar K, Lalloo DG, Beeching NJ, Hunt BJ. Rotational Thromboelastometry Alongside Conventional Coagulation Testing in Patients With Crimean-Congo Haemorrhagic Fever: An Observational Cohort Study. Lancet Infect Dis 2019;8:862-871.

Sharun K, Dhama K, Patel SK, Pathak M, Tiwari R, Singh BR, Sah R, Bonilla-Aldana DK, Rodriguez-Morales AJ, Leblebicioglu H. Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19. Ann Clinmicrobiol Antimicrob 2020;19(1):23.